Seastar Medical Holding revenue was $881.00k for the trailing 12 months ending Sep 30, 2025, with N/A growth year over year. Quarterly revenue for the quarter (Q3 2025) ending on Sep 30, 2025 was $183.0k, down 45.9% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, ICU annual revenue was $135.0k, with Infinity% growth year-over-year.
ICU past revenue growth
How has ICU's revenue growth performed historically?
Seastar Medical Holding (NASDAQ: ICU) reported Q3 2025 revenue of $183.00 thousand up 169.12% year over year. In the same quarter last year, Seastar Medical Holding's revenue was $68.00 thousand.
What was Seastar Medical Holding's revenue in 2024?
Seastar Medical Holding's annual revenue for the twelve months ending Dec 31, 2024 was $135.00 thousand, a Infinity% increase year over year.
How much does Seastar Medical Holding make in a day?
Based on Seastar Medical Holding annual revenue for the past four years, ICU makes an average of $92.47 per day.
What was Seastar Medical Holding's annual revenue growth in the past year?
As of Q4 2025, Seastar Medical Holding's revenue has grown 1,195.59% year over year. This is 900.59 percentage points higher than the US Biotechnology industry revenue growth rate of 294.99%. Seastar Medical Holding's revenue in the past year totaled $881.00 thousand.
How much does Seastar Medical Holding make in a year?
Seastar Medical Holding's revenue by year for the past four years is:
Seastar Medical Holding's revenue for the twelve months ending Dec 31, 2024 was $135.00 thousand, a Infinity% increase year over year.
Seastar Medical Holding's annual revenue for Dec 31, 2023 was $0.00, a N/A decrease from 2022.
Seastar Medical Holding's annual revenue for 2022 was $0.00, a N/A decrease from 2021.
Seastar Medical Holding's annual revenue for 2021 was $0.00, a N/A decrease from 2020.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.